Virginia Cannabis News

The provided text is a newsletter from Marijuana Moment, dated July 24, 2025. Key topics include the retirement of the DEA judge overseeing marijuana rescheduling, comments from the VA Secretary on psychedelics, the DEA's drug emoji guide, Texas Governor Greg Abbott's evolving stance on hemp, a court ruling on cannabis consumers' gun ownership, and the stepping down of the National Cannabis Industry Association CEO...

A new bill in Pennsylvania, SB 926, aims to protect parents who are medical marijuana patients from losing child custody or being subjected to drug tests solely based on their patient status. This legislation, introduced by Sen. John Kane, seeks to clarify existing state law and prevent lawful medical marijuana use from being used against parents in custody disputes. The push for this reform is happening alongside a broader effort to legalize adult-use marijuana in Pennsylvania, with several other bills and proposals currently under consideration, facing bipartisan support and opposition within the legislature.

Pennsylvania House Democrats are urging voters to pressure state senators to pass HB 1200, a bill to legalize marijuana and sell it through state-owned stores, citing health, safety, and revenue benefits. The bill narrowly passed the House but was rejected by a Senate committee. Despite bipartisan support among voters, the reform faces opposition from Senate Republicans. Other legalization proposals are in discussion, and supporters believe growing public sentiment will help overcome legislative hurdles. The governor also supports legalization, emphasizing competitiveness with surrounding states.

Senators Advance Bill Continuing Medical Marijuana Protections And Omitting House Proposal To Block Rescheduling

A Republican Pennsylvania senator, Dan Laughlin, believes that supporters of marijuana legalization are gaining votes to pass reform this session. He states that people prefer legalizing cannabis for revenue rather than increasing taxes to balance the budget. Laughlin, along with Sen. Sharif Street, introduced a bill to legalize adult-use cannabis. There are also other proposals, including a House companion version, under consideration. Despite previous setbacks, lawmakers are optimistic about passing a bill that would also include sealing and expunging cannabis-related convictions. However, there are conflicting views on the model of cannabis sales (state-run vs. private businesses) and the political dynamic with a GOP-controlled Senate. Despite these challenges, polls show strong public support for legalization. The governor also supports legalization, emphasizing economic benefits and public safety.

Trump Signs Fentanyl Criminalization Bill That Could Also Open Up Research On Marijuana, Psychedelics And Other Schedule I Drugs

A Democratic Pennsylvania House lawmaker, Rep. Amen Brown, has filed a new marijuana legalization bill, mirroring a bipartisan Senate proposal. He argues that legalization would expand patient access, strengthen the state's cannabis infrastructure, ensure product safety, combat the black market, and address disproportionate arrests in communities of color. Brown emphasizes the economic benefits, citing other states, and warns against high tax rates that could drive consumers to illicit markets. Other lawmakers have also introduced similar bills, highlighting the bipartisan support and economic opportunities for Pennsylvania. Despite broad public support, legislative efforts have faced hurdles, particularly regarding state-run stores and the need for Republican support in the Senate.

Home values have increased more in states where recreational marijuana is legal compared to where it is illegal. In 2024, the typical home in a recreational state was worth 39% more than in non-recreational states. Similarly, homes in states with legal medicinal marijuana are worth about 18% more than in illegal states. The report also lists the top ten states with the highest and lowest home value increases since 2009, highlighting the correlation with cannabis legalization. Clever Real Estate is the source of this report.

A new study by Clever Offers shows that home values in states where adult-use marijuana is legal have increased by $60,327 more on average between 2009 and 2024 compared to states where it remains criminalized. The report states that recreational cannabis states saw an average home value increase of $222,958, while non-legal states saw an average increase of $162,631. As of 2024, the average house in a legal marijuana state was worth $447,635, about 39% more than the average house price in non-recreational states. The study also found that states with only medical marijuana legalization saw greater home price increases ($22,185 more) than states where cannabis remains outlawed. While legalization is not the sole driver, tax revenue from legal cannabis is reinvested into public programs, making neighborhoods more desirable.

A congressional committee approved a spending bill that includes provisions to block the Justice Department from rescheduling marijuana and maintains protections for state medical cannabis programs, with new language for enhanced penalties for sales near schools. The bill would specifically prevent the Justice Department from using funds to reschedule or deschedule marijuana. The Drug Enforcement Administration's marijuana rescheduling process remains stalled. Separately, discussions around marijuana policy reform and rescheduling efforts continue among politicians and advocates.

A new study in the journal Pharmacy indicates that chronic pain patients who used medical marijuana for at least one year had lower healthcare utilization, including fewer urgent care and emergency department visits, and reported a higher quality of life. The study, involving over 5,000 patients, suggests that medical cannabis is an effective treatment for chronic pain and can lead to positive effects on the healthcare system. Other recent research also supports medical marijuana's role in pain management, its potential to reduce opioid use and related harms, and its cost-effectiveness as an alternative therapy for various conditions.

DMV cannabis news. Source Newsletter.

Bipartisan lawmakers in Pennsylvania have filed new bills to legalize marijuana. The House has filed legislation establishing the Keystone Cannabis Authority and the Community Opportunity Fund, aiming to close a budget gap and create jobs. Meanwhile, a companion bill to a Senate legalization proposal is also expected to be filed in the House. Lawmakers supporting legalization emphasize economic opportunity, justice, equity, and responsible regulation, including expungement of low-level offenses. The governor has called for adult-use marijuana legalization, stressing competitiveness and the need to address the illicit market. Despite bipartisan support among voters, legislative efforts have stalled due to conflicting views, particularly on state-run stores versus private sales, and the need for Republican support in the Senate.

The provided text summarizes a Marijuana Moment newsletter from July 14, 2025. Key topics include accusations of child labor violations against a marijuana business, a congressional amendment for psychedelic medical trials, and a Wisconsin GOP gubernatorial candidate open to marijuana legalization. Other points cover a former NFL player's meeting with White House officials about cannabis rescheduling, a study on psilocybin and ayahuasca improving veterans' mental well-being, and various state-level updates on cannabis regulations and market launches. Federal officials are also discussing immigration raids on cannabis businesses and related political rhetoric.

A bipartisan bill to legalize recreational cannabis in Pennsylvania was introduced by Senators Dan Laughlin and Sharif Street, but it faces opposition from Senate Majority Leader Joe Pittman, who does not see a prevailing view for legalization within the Republican caucus as part of the current budget negotiations. The bill proposes legalizing cannabis for those 21 and over, with a 6% sales tax and 8% excise tax, and would expunge non-violent cannabis convictions. Despite broad Democratic support and calls from Gov. Josh Shapiro, similar measures have struggled to pass the GOP-controlled Senate, particularly due to a previous proposal that would have sold cannabis in state stores, which was a nonstarter for many.

The author, Ryan Basore, a former federal prisoner for medical cannabis cultivation, launched Redemption Cannabis and the Redemption Foundation. His cannabis brand is now available in West Virginia, where he was incarcerated. The Redemption Foundation provides expungements and financial support to non-violent cannabis offenders still in prison, partnering with organizations like Mission Green and the Last Prisoner Project. Basore emphasizes that despite widespread legalization, many people remain incarcerated for cannabis offenses, and federal law, which classifies cannabis as a Schedule I drug, needs to change for true justice. He states that 10% of Redemption Cannabis licensing revenue supports incarcerated individuals and their release, highlighting that buying their products contributes to the pursuit of justice.

Redemption’s flower is sold at the company’s dispensaries, and a portion of each sale is reinvested in communities affected by prohibition.

The provided text is a newsletter from "Marijuana Moment" dated July 11, 2025. Key topics include: a Senate committee approving a delayed ban on consumable hemp products with THC; ICE raids on state-licensed marijuana farms; former House Speaker Newt Gingrich's support for psychedelic therapy; Texas Gov. Greg Abbott's opposition to a blanket hemp prohibition; California's advancement of cannabis tax reform; Delaware lawmakers seeking feedback on recreational cannabis sales; and a federally funded study finding THC-dominant medicinal cannabis reduces anxiety and depression. Other sections cover federal and state news, local developments, international cannabis policies, science and health studies, advocacy opinions, and business updates in the cannabis industry.

Bipartisan Pennsylvania Senators Dan Laughlin (R) and Sharif Street (D) have filed a bill to legalize adult-use marijuana in the state. The legislation aims to create a Cannabis Control Board, protect consumers, expunge past offenses, and reinvest in communities impacted by prohibition. Supporters highlight the economic benefits and the need for Pennsylvania to catch up with neighboring states that have already legalized cannabis. While there is bipartisan support among voters, the reform has faced legislative hurdles, particularly in the GOP-controlled Senate. Governor Josh Shapiro (D) has also called for legalization, emphasizing the economic advantages and the need to regulate the illicit market.

This newsletter from Marijuana Moment on July 10, 2025, covers various cannabis-related news. Key topics include an Oklahoma legalization ballot measure, Hawaii's governor signing a hemp bill, California's marijuana decriminalization 50th anniversary, and a study on Pennsylvania's medical cannabis and anxiety. Other updates include Virginia's cannabis commission planning legal sales, Alabama's stalled medical cannabis licensing, and differing hemp legislation in North Carolina. Federal news covers Customs and Border Protection blocking a man due to marijuana offenses, and Rep. Thomas Massie citing hemp legalization. State news includes California allocating marijuana revenue to combat impaired driving, Florida removing illegal hemp products, Ohio Republicans opposing efforts to undermine legalization, and Colorado regulators sending a bulletin about revoked marijuana licenses. International news mentions a Canadian senator joining an Australian drug policy reform organization. Science and Health sections highlight a review on nano-CBD platforms and a study on psilocybin for depression in veterans. Business news includes Auxly Cannabis Group Inc. closing debt reduction transactions and Canopy Growth Corporation having a new interim chief financial officer. The newsletter encourages subscriptions and support via Patreon.

A newly re-established cannabis commission in Virginia held its first meeting to discuss the future of marijuana in the commonwealth. The commission aims to create a successful approach to cannabis rooted in public protection, restorative justice, economic equity, and public health, with the goal of crafting a bill to legalize retail sales. Despite marijuana use being legal since 2022, retail sales are forbidden due to Governor Glenn Youngkin's vetoes. The commission will gather public input and make recommendations, with future meetings scheduled through 2028. Key goals include generating revenue for community reinvestment, creating small businesses, strengthening agriculture, addressing racial inequities, protecting public health, and increasing funding for pre-K education.

This newsletter from Marijuana Moment covers various cannabis and psychedelics-related news. Key topics include a federal judge upholding a gun ban for marijuana users, a former Navy SEAL discussing psychedelic therapy for PTSD, and a scientific review on what gives cannabis strains their aroma and flavor. It also highlights a study on cannabis consumption in California, Maryland's plan for a state-owned cannabis incubator, and updates on cannabis legislation and regulation in several states. Other sections touch on international drug policy, science and health studies related to cannabis and psychedelics, and business news in the cannabis industry.

A Navy SEAL veteran, Rob O’Neill, known for killing Osama Bin Laden, states that psychedelic therapy has helped him with PTSD and believes it should be a readily available treatment option for veterans in the U.S. He uses ibogaine in Mexico annually to manage his symptoms, emphasizing that it works better than alcohol for trauma. Various organizations are assisting veterans in accessing psychedelic treatments abroad, and there's a growing push for domestic access, with bipartisan congressional support and commitment from federal agencies like HHS and VA to expand research and access to substances like MDMA, ibogaine, and psilocybin for military veterans.

New York-based Cannabis Public Policy Consulting LLC was awarded a $238,700 contract to study Missouri's marijuana market for the next year. The study aims to determine if and when the state needs to issue additional cannabis facility licenses, and to provide information on the economic stability of the regulated market, including its impact on economically distressed areas. Missouri's cannabis market has been successful, with $1.46 billion in sales in 2024, partly due to limiting the number of licenses. The study will also help create a plan to promote ownership and employment in the marijuana industry for people from economically distressed areas.

Summary: D.C., Virginia and Maryland cannabis news from June 25 to July 1, 2025.

The July 2, 2025, Marijuana Moment newsletter covers various cannabis-related news. Key topics include the Virginia commission preparing for legal recreational sales, Florida's governor signing a bill to revoke medical cannabis registrations for certain drug crimes, Pennsylvania senators filing a bill for a Cannabis Control Board, and Delaware announcing recreational sales will begin on August 1. Other updates include federal discussions on cannabis and psychedelics, state-level changes in marijuana taxes and regulations, and scientific studies on CBD and psychedelic-assisted therapy. The newsletter also mentions business news, such as Trulieve Cannabis Corp. filing a shelf registration and TerrAscend Corp. exiting the Michigan market.

Nebraska Gov. Jim Pillen has approved emergency rules for licensing medical cannabis establishments, with licensing to begin by October 1. The regulations were imposed by voters last November, legalizing medical cannabis with a healthcare practitioner's recommendation. The Nebraska Medical Cannabis Commission will regulate the new medicine. The rules set criteria for licenses (cultivator, manufacturer, dispensary, transporter), including ownership, fingerprinting, location restrictions, and prohibited persons. Dispensaries are limited to one per judicial district and can sell specific products like oral tablets, tinctures, gels, and patches, but not raw plant, edibles, or products for smoking/vaping. Public feedback on the emergency regulations is open until July 15. Advocates have expressed concerns about the ban on whole-plant cannabis and restrictions on usage methods. Formal regulations are expected to follow the emergency guidelines.

Delaware's adult-use marijuana market will launch on August 1, 2025, after delays due to FBI background check issues. The state will issue 125 licenses, including for retailers, cultivators, manufacturers, and testing labs, with portions reserved for social equity applicants and microbusinesses. Governor Matt Meyer celebrated the new industry, highlighting its potential to generate revenue and create opportunities. The state's medical marijuana program also saw significant expansion in July, allowing doctors to recommend cannabis for any condition and enabling patients over 65 to self-certify.

A new Virginia government cannabis commission will meet next week to discuss future marijuana laws, likely leading to a revised proposal for retail sales. While marijuana use and possession have been legal since 2022, retail sales are still forbidden, fueling an illicit market. Governor Glenn Youngkin has twice vetoed proposals for regulated sales, but with his term ending, the next governor will likely decide the fate of retail cannabis. The commission, in place until mid-2028, will gather public input and make recommendations on various policy matters for Virginia's transition to a commercial adult-use market, including licensing, taxes, employment protections, and labor union agreements. Advocacy groups like Marijuana Justice and NORML plan to participate, while the Virginia Cannabis Association does not, focusing instead on reintroducing previously vetoed legislation. The outcome of the upcoming gubernatorial election is seen as crucial for the future of cannabis retail in Virginia.

Pennsylvania senators have introduced a bipartisan bill to create a new regulatory body, the Cannabis Control Board (CCB), to oversee medical cannabis and prepare for eventual adult-use legalization. The bill, sponsored by Senator Dan Laughlin, aims to establish a transparent and efficient framework for the cannabis industry, ensuring the state is ready when adult-use legalization passes. The CCB would consolidate oversight, enhance transparency, and manage the industry. While the bill doesn't explicitly legalize adult-use cannabis, it sets up the infrastructure for it. Democrats and some Republicans support legalization due to public health and safety concerns, economic benefits, and competitiveness with neighboring states that have already legalized. Despite bipartisan voter support, the reform faces hurdles in the legislature due to conflicting views on a state-controlled versus private sales model and the need for Republican support in the GOP-controlled Senate.

White House Announces Withdrawal Of Trump’s Drug Czar Nominee Who Embraced Medical Marijuana

* GOP senator: Regulate marijuana like alcohol; Bill to increase hemp THC limit; Survey: Cannabis industry workers happy; OH legalization change delay.
* The U.S. House of Representatives approved amendments to let Department of Veterans Affairs doctors recommend medical cannabis and to support research on the therapeutic benefits of psychedelics.
* Sen. Thom Tillis (R-NC) said marijuana legalization opponents “have lost” the debate and that “it’s time” to create a regulatory framework treating cannabis “the same way that we do with alcohol and tobacco” so states can set their own policies without federal intervention.
* Sen. Rand Paul (R-KY) filed a bill to triple the amount of THC that can legally be in hemp and to make other changes to federal rules for the crop to address industry concerns.
* Hourly workers in the marijuana industry rank at the top of the list of “happiest” employees across multiple sectors, according to a new survey from Deputy—with more than 9 in 10 reporting a “positive sentiment” in their job.
* Thailand’s public health minister signed an order requiring people to have doctors’ prescriptions and medical certificates mandatory in order to buy cannabis.
* A study found that “since 2012, there has been considerable growth in patents and publications related to cannabis drug delivery systems, driven by the therapeutic potential of cannabinoids.”
* A poll found that Australians support legalizing marijuana, 48 percent to 41 percent.
* Verano Holdings Corp. is opening a bodega-style dispensary in Phoenix, Arizona.

D.C., Virginia, and Maryland cannabis news from June 18 to June 24, 2025.

* Federal hemp ban advances.
* RFK wants psychedelics available in 12 months.
* Pennsylvania legalization debate.
* Montana governor vetoes tribal cannabis bill.
* Texas hemp regulations.
* The House Appropriations Committee approved a spending bill containing provisions to ban most consumable hemp-derived cannabinoid products.
* The House Rules Committee cleared amendments to let Department of Veterans Affairs doctors recommend medical cannabis and to support research on the therapeutic benefits of psychedelics for floor votes this week.
* Texas’s lieutenant governor decided to ban all synthetic cannabis including Delta 8, Delta 10, and others.
* A review concluded that purified cannabidiol was reported to reduce seizure frequency ranging between 30% and 50%.
* Tilray Brands, Inc. announced that it is the first company to receive authorization from Italian officials to import and distribute medical cannabis flower for therapeutic use.

Bloom Brand, a U.S. leader in cannabis vape, is expanding internationally with a launch in the UK in Q1 2026 through a partnership with New Garden Pharma. This marks Bloom's first international market expansion, with plans for further EU market development in 2026 and beyond. The partnership will provide UK patients access to Bloom's vape collections. New Garden Pharma will lead the UK entry, ensuring a compliant and scalable launch.

A key Pennsylvania senator is working with lawmakers to develop a marijuana legalization bill before the budget deadline. The senator stated they are getting close to passing a bill and want to ensure it is equitable. Other lawmakers are also emphasizing the revenue-generating potential of legalization. While some are hopeful, the Senate Majority Leader said legalization will not be included in the 2026 budget.

The provided text is a newsletter from Marijuana Moment. Key topics include: a clash between Texas Gov. Greg Abbott and Lt. Gov. Dan Patrick over hemp regulation; a poll showing support for marijuana reform among US voters; a DEA judge's decision on psychedelic compounds; and a Supreme Court case regarding marijuana users' gun rights. The newsletter also covers state and local news, international developments, and scientific studies related to cannabis.

State legislatures considered criminal justice reform bills related to marijuana, but many failed. The Last Prisoner Project (LPP) calls this the "hidden crisis in cannabis reform." Bills to seal records and release incarcerated individuals fell short in several states. Virginia's resentencing bill was vetoed. However, Maryland and Hawaii saw landmark victories in record relief and expungement. LPP advocates for addressing past drug war harms and urges action on cannabis justice.

A Pennsylvania Republican says marijuana legalization will not be included in the 2026 budget, but Gov. Josh Shapiro hopes for a compromise. The budget deadline is June 30. Shapiro supports legalization, as do many Pennsylvanians, but Senate Republicans are resistant. The House passed a legalization bill, but it was rejected by a Senate committee. Lawmakers are divided, but some are aiming for a compromise. A recent poll shows majority support for legalization. The governor emphasizes the state is "losing out" to others that have already enacted adult-use legalization.

VA Secretary Doug Collins visited a psychedelics research center, emphasizing his commitment to exploring therapeutic benefits for veterans. He discussed policy changes and congressional support, highlighting ongoing clinical trials with MDMA and psilocybin. Collins also mentioned a meeting with HHS Secretary Robert F. Kennedy Jr. and support for vouchers for psychedelic therapy.

Washington, D.C. is cracking down on unlicensed cannabis businesses. Maryland collected over $17.5 million in cannabis taxes in Q1 2025. The owner of Zarati shops in Virginia reached a plea deal in a drug and money laundering case.

*TX gov on hemp ban; FL medical marijuana patient penalty; OR appealing cannabis labor ruling; Petition on Facebook’s drug censorship; AK psychedelics*

GOP senators filed a bill to increase penalties for marijuana edibles; Wisconsin may legalize marijuana; Capitol Hemp is suing the federal government; a Colorado healing center administered the first psilocybin session; Snoop Dogg launched a new cannabis platform.

A coalition of Republican senators have reintroduced a bill that would increase criminal penalties for a wide range of offenses, including manufacturing or selling Schedule I drugs like marijuana in the form of candy or beverages if there is “reasonable cause to believe” they will be sold to minors. The bill targets substances in Schedule I or II of the federal Controlled Substances Act (CSA), including cannabis. The legislation doesn’t explicitly mention marijuana, but a section-by-section analysis says that manufacturers and traffickers of marijuana edibles and fentanyl and other illicit drugs are marketing and distributing these highly dangerous drugs as packaged candy. If enacted, people who are federally prosecuted for such criminal activity could face up to 10 additional years in prison for a first offense if the cannabis product sold to a person under 18 was shaped or flavored like candy. Second and subsequent offenses would carry up to 20 additional years in prison.

Congress sent President Donald Trump a bill to permanently ban fentanyl
analogues—including additional provisions that Rep. Morgan Griffith (R-VA)
says would remove barriers to research on marijuana and other Schedule I
drugs...

Iowa Gov. Kim Reynolds vetoed a bill allowing doctors to prescribe psilocybin upon federal approval. The bill, HF 383, would have reclassified a form of psilocybin, but Reynolds cited concerns about state readiness and legal uncertainty. Lawmakers also considered a broader psilocybin bill, HF 978, which has not advanced.

Congress passed a bill banning fentanyl analogues, but also allowing more research into marijuana and other Schedule I drugs. The House approved the HALT Fentanyl Act, which streamlines research into Schedule I drugs like marijuana, but critics worry it will increase mandatory minimum sentences. The bill also aims to expedite registrations for studies into Schedule I drugs.

Easyday Edibles’ Vision, Proposed Craft Endorsements, and the Harris Rider lives...

Mountain High Seltzer is the first THC seltzer to be distributed by Hoffman Beverage and Virginia Eagle, an Anheuser-Busch wholesaler.

Hawaii Gov. Josh Green (D) intends to veto a controversial marijuana bill due to privacy concerns. The bill would have allowed patients to enroll in the state’s medical cannabis program for any health condition. The governor cited a provision allowing access to medical marijuana patient records as a “grave violation of privacy.”

A GOP congressman says he’s “excited” to work with the Trump administration
to advance psychedelics reform, expressing enthusiasm about federal health
officials who appear “friendlier” to the issue compared to those who served
under past presidents.

In an interview with Fox News, Rep. Dan Crenshaw (R-TX) talked about his
work to secure funding for studies into the therapeutic benefits of
psychedelics such as psilocybin, MDMA and ibogaine—including the passage of
legislation to require Department of Defense (DOD) clinical trials into
such substances for active duty service members that then-President Joe
Biden signed into law.

The Nevada legislature approved a resolution urging Congress to reschedule psychedelics, streamline research, and protect those using them under state law. The resolution calls for rescheduling specific psychedelics, increasing research funding, and establishing legal protections for those complying with state law. Additionally, lawmakers are considering a measure allowing people with past marijuana possession convictions to become foster parents.

A new study indicates that hotel revenue increases by 25.2% (or $63,671 monthly) due to dispensary legalization, with the effect continuing to grow. The study found that hotels closer to dispensaries and in resort areas benefit the most.

*Fed hemp product ban; USDA marijuana & food stamps update; TX gov mum on hemp ban; ME psilocybin; OH ups cannabis purchase limits; Alcohol exec op-ed*

The House Appropriations Subcommittee on Agriculture unveiled a bill to ban most consumable hemp-derived cannabinoid products. The USDA issued updates on the use of federal welfare benefits to buy cannabis. North Carolina Gov. Josh Stein endorsed marijuana legalization. Texas Gov. Greg Abbott will not reveal if he will sign a bill to ban consumable hemp products with any amount of THC. The Maine Senate passed a bill to legalize possession of psilocybin. New Ohio rules more than double the amount of marijuana that recreational consumers can purchase. Wine & Spirits Wholesalers of America President argues that the alcohol industry’s regulatory structure is a good model for intoxicating hemp beverages.

*PA gov on legalization; ME psilocybin; CA marijuana tax bill passes; TX hemp petitions; Ukraine medical cannabis import*

The Pennsylvania governor is hopeful that lawmakers will deliver a marijuana legalization bill by the end of the month. He's urging the GOP-controlled Senate to put their ideas on the table. The governor sees this as an issue of competitiveness, as neighboring states have legalized it. Discussions are ongoing, and the governor hopes for a budget package by the end of the month.

D.C., Virginia and Maryland cannabis news May 28 to June 2, 2025. Source

D.C., Virginia and Maryland cannabis news May 20 to May 27, 2025.

Source

Virginia Gov. Glenn Youngkin vetoed legislation that would have improved labeling on medical cannabis products and codify permissible locations for the delivery of medical cannabis products. Youngkin said that while he approved of the labeling changes, the delivery provisions raised “public safety and regulator concerns.” JM Pedini said Youngkin’s claims that the bill “would have expanded marijuana access are categorically false.” The veto is Youngkin’s third this legislative session related to cannabis policy in the state.

A bill to legalize cannabis for adult use was introduced this week in Pennsylvania by Democratic Reps. Rick Krajewski and Dan Frankel. The proposal includes criminal justice reforms and social equity provisions, such as reinvesting tax revenues into communities most affected by the War on Drugs. The bill calls for "publicly owned and accountable retail stores" and will first be heard in the House Health Committee.

Sister Somayah Kambui was a veteran Black Panther who advocated for racial justice in the cannabis movement. She won a groundbreaking legal victory, allowing her to provide cannabis to treat sickle-cell anemia. Kambui was arrested and faced a life sentence, but was found not guilty. She was also a leading figure in the cannabis activist scene, and her work highlighted the need to support freedom fighters.